PitchBook News - VC in China begins bouncing back

Fintech booms amid social distancing; Biotech firms raise new mega-funds; Data startup reaches $2.3B valuation; Germany gives startups $2.2B boost
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Daily Pitch: VC
April 3, 2020
Like our newsletter? The data comes from the PitchBook Platform — our data software for VC, PE and M&A
Today's Top Stories
Impact on investors from travel curbs
Thank you to the almost 400 VC, PE and LP readers who responded to our investor survey this week.
  • Some of the results reflect a surprising degree of positive sentiment despite unprecedented turmoil in the economy.

  • Readers weighed in on the headwinds the industry is facing as a result of restrictions on travel and other movement outside the home. A majority of respondents said they find the measures a genuine impediment to fundraising activity.

  • After 2019 set an annual record for fundraising, PitchBook analysts expected 2020 to remain strong but not to surpass last year's totals, given industry cycles. But forecasts might need to drop even further if travel restrictions stretch beyond April. PitchBook analysts have underscored this challenge—especially for first-time managers—as LPs seem likely to be more comfortable working remotely with GPs through existing relationships.

  • Next week, we'll share more analysis of investors' outlook.
More coronavirus news: Continuing coverage from PitchBook
Share:   Email    LinkedIn    Twitter    Facebook
The pandemic is transforming private market strategies for LPs
A police offer stands outside Mount Sinai Hospital in New York. (Spencer Platt/Getty Images News)
The COVID-19 pandemic's ripple effects across private financial markets continue to widen. The latest research note from our analysts is dedicated to exploring how allocators to private fund strategies are adapting to the crisis. A few key findings:
  • As a group, LPs are better positioned to combat the denominator effect today than during the global financial crisis
     
  • LPs allocating to PE and VC funds can expect net cash flows to turn negative
     
  • Many VC funds are likely to shift some of their expenditures toward sustaining portfolio companies
read it now
 
Share:   Email    LinkedIn    Twitter    Facebook
A message from NSF
Invention to impact
NSF
Moxi, the nurse assistant robot created by Diligent Robotics, takes on mundane hospital chores and could help reduce healthcare professionals' exposure to disease. The Texas-based company recently raised $10 million to make more robots.

Diligent Robotics is one of hundreds of deep technology startups funded each year by the National Science Foundation (NSF), a government agency that plays a central role in accelerating deep technologies out of the laboratory and into the marketplace.

Each startup can receive up to $1.75 million to support research and development aligned with commercialization goals. The NSF team is a group of experts drawn from the technology startup and investment community, committed to identifying and supporting these new firms from launch to commercialization.

NSF helps these teams navigate the earliest stages of technology translation and on to marketplace success, investing roughly $200 million annually in small businesses like Diligent Robotics. In the last five years, these companies have gone on to raise more than $7 billion in follow-on capital and nearly 100 exits.

Learn more about NSF funding for deep technology startups today on seedfund.nsf.gov.
Share:   Email    LinkedIn    Twitter    Facebook
China's VC industry bounces back after coronavirus-induced winter
Wuhan, China on April 2, 2020 (Getty Images News)
Dealmaking in China is springing back to life after a dramatic decline in venture capital activity for January and February.

The resilience is an encouraging sign for VCs and startups in the US and Europe who are starting to feel the impact of government-mandated containment measures and turmoil in the markets.

But it's possible that China's uptick may not last for long, and there's always a danger that COVID-19 cases will climb again, spurring more lockdowns:
read more
 
Share:   Email    LinkedIn    Twitter    Facebook
Biotech-focused VC firms raise billions
(Matthias Tunger/DigitalVision/Getty Images)
The coronavirus outbreak has derailed many VC fundraising efforts. But it didn't stop two healthcare-focused VC firms from unveiling new mega-funds Thursday that could potentially make bets on companies developing coronavirus-focused therapeutics, vaccines and more.

ARCH Venture Partners has raised $1.46 billion for its 10th flagship fund and a related overage fund, both of which will be dedicated to early-stage biotech companies. The Chicago-based firm already backs a handful of companies working on COVID-19 therapeutics, as well as Twist Bioscience, a developer of gene engineering tools used in COVID-19 therapeutics and vaccine development.

Life sciences firm Flagship Pioneering, meanwhile, has raised $1.1 billion for its seventh Origination Fund, which it will use to help create new biotech companies within its Flagship Labs unit. The vehicle will focus in part on startups developing therapies intended to improve societal health defenses before diseases escalate. Past companies formed by the Boston-based firm include Moderna Therapeutics, which worked on the first possible COVID-19 vaccine to go into clinical trials.

In an effort to extend cash runways, several biotech companies have begun to halt or reassess their drug development and clinical trial budgets, according to a new PitchBook analyst note on the effects of the coronavirus outbreak on venture capital.
Share:   Email    LinkedIn    Twitter    Facebook
Weekly VC Recap
In case you missed it:

• We unpacked what a $2 trillion stimulus plan will and won't do for the private markets.

• In an effort to restore its credit rating and investor confidence, SoftBank is planning a $41 billion asset sale that includes parceling off what's arguably the tech investor's most prized possession.

• With college campus closures sweeping the nation, US-based VC investors are racing to support home-bound student entrepreneurs.
(Georgia Kuhn/Cultura/Getty Images)
• Complications of the coronavirus can be particularly deadly for smokers, resulting in a demand surge for startups trying to help people quit.

• As they face unprecedented challenges, gig workers are taking back power and claiming early wins.

• In the most recent edition of the PitchBook PlayBook, we took a look at how meat and dairy companies are fighting back against the growing plant-based market.
Share:   Email    LinkedIn    Twitter    Facebook
Fintech startups set to soar as pandemic drives consumers online
(Witthaya Prasongsin/Moment/Getty Images)
As the coronavirus outbreak ravages the global economy, more and more consumers are opting for digital-only financial services.

PitchBook chatted with a handful of professionals in the industry, and it appears some fintech startups could reap long-term benefits from the ordeal:
read more
 
Share:   Email    LinkedIn    Twitter    Facebook
Germany unleashes $2.2B boost for startups
The German government has launched a support package worth €2 billion (about $2.2 billion) for startups affected by the coronavirus. The state will work through venture capital firms that will distribute the funds to the struggling businesses. It will also enable the umbrella funds KfW Capital and the European Investment Fund to use public capital to replace money withdrawn by other investment funds.

Separately, Germany announced that farmers, small businesses and the self-employed could now apply for benefits under a €50 billion economic assistance program passed by the country's parliament on April 1. Both programs are part of the country's existing uncapped aid for all businesses struggling with the economic ramifications of the virus.
Share:   Email    LinkedIn    Twitter    Facebook
Recommended Reads
What it's like to work for Instacart during a pandemic. [Rolling Stone]

An open letter to Jeff Bezos from an Amazon worker who was fired for violating a company-imposed quarantine after helping lead a protest at one of the company's warehouses. [The Guardian]

Sports fees are one of the priciest line items on many a cable bill. Now, with games on an indefinite hiatus, some customers are looking for a refund. [The New York Times]

A brief history of the CIA's infatuation with modern art. [JSTOR Daily]
Ads
Since yesterday, the PitchBook Platform added:
6
VC valuations
1053
People
311
Companies
13
Funds
See what our data software can do
 
Today's Headlines
  The Daily Benchmark  
  2010 Vintage US PE Funds  
  VC Deals  
  Collibra hits $2.3B valuation  
  French biotech startup reels in $54M  
  Phantom AI drives off with $22M Series A  
  Telehealth startup tallies $6M  
 
 
The Daily Benchmark
2010 Vintage US PE Funds
Median IRR
11.99%
Top Quartile IRR Hurdle Rate
19.22%
1.59x
Median TVPI
Select top performers
Ticonderoga KI
Lone Star Fund VII
CIVC Partners Fund IV
*IRR: net of fees
36 Funds in Benchmark »
Check out the latest version of PitchBook Benchmarks
VC Deals
Collibra hits $2.3B valuation
Data intelligence company Collibra has raised $112.5 million in a round co-led by Iconiq Capital and Index Ventures, bringing its valuation to $2.3 billion. Founded in 2008 and based out of Brussels, the company has raised $345.5 million in VC financing to date.
Additional Investors:
CapitalG, Battery Ventures, Durable Capital Partners, Dawn Capital
View round
 
View 131 competitors »
 
French biotech startup reels in $54M
Dynacure has raised €50 million (about $54 million) in a Series C led by Perceptive Advisors, with participation from Bpifrance and Tekla Capital Management. The French biotech company will use the funds to pursue a clinical trial for the treatment of myotubular and centronuclear myopathies and other rare genetic muscle disorders.
Additional Investors:
Andera Partners, Kurma Partners, Pontifax Venture Capital
View round
 
View similar company »
 
Phantom AI drives off with $22M Series A
Phantom AI has raised $22 million in a round led by Celeres Investments, with participation from Ford, KT, Millennium Technology Value Partners and DSC Investment. The California-based company offers technology to help reduce vehicle accidents.
View round
 
View similar company »
 
Telehealth startup tallies $6M
SteadyMD has raised $6 million in a Series A co-led by Pelion Venture Partners and Next Ventures. The St. Louis-based startup is a creator of software that pairs users with doctors available for appointments over text, phone or video chat. It was valued at $18.6 million with a funding round in August, according to PitchBook data.
Additional Investors:
Crosscut Ventures, First Trust Capital Partners, Hyde Park Venture Partners, M25, Wild Ventures
View round
 
View 20 competitors »
 
Chart of the Day
"Another way GPs have approached the technology sector is through add-on deals. In 2019, the sector reached a new high of 20.6% of all add-on deal value, second only to B2B at 32.2% (down from 36.9% in 2018)."

Source: PitchBook's 2019 Annual US PE Middle Market Report
About PitchBook | Terms of use | Advertise with us | Contact

Follow us:   in   twtr   fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

© 2020 PitchBook Data. All rights reserved.
Venture capital, private equity and M&A financial information technology provider.

Older messages

Alibaba share sale could spur SoftBank

Thursday, April 2, 2020

SoftBank opts against WeWork deal; Collaboration startup Notion valued at $2B; How COVID-19 is impacting supply chains; Biotech startup eyes $75M IPO Read online | Don't want to receive these

How COVID-19 will impact VC in the US

Wednesday, April 1, 2020

Startups helping cooped-up smokers quit; General Catalyst banks $2.3B for fund trio; VCs to sell CloudGenix for $420M; Cybersecurity startup nets $58M Read online | Don't want to receive these

Instacart shoppers plan massive strike

Monday, March 30, 2020

Layoffs hit startups Bird, Getaround; Industry giants take on alt-meat startups; Vaccine developer raises $110M; Data-mining startup secures $300M Read online | Don't want to receive these emails?

What a $2T stimulus means for VC

Saturday, March 28, 2020

Emerging tech startups cope with COVID-19; Lime could see $2B valuation dip; VCs aim to aid student entrepreneurs; Airbnb to house healthcare workers Read online | Don't want to receive these

A pandemic shakes up the private market

Wednesday, March 25, 2020

Mental health startups aim to help amid virus; Bakkt banks $300M funding; 12/12 Ventures eyes $100M cannabis fund; Edtech startup sells for $250M Read online | Don't want to receive these emails?

You Might Also Like

MAILBAG! FCS Bowl Games, FBS regular season expansion, and more:

Wednesday, November 27, 2024

Plus, EVEN MORE EXTRA POINTS BOWL PICTURES ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Into the black

Wednesday, November 27, 2024

Offshore crypto-gambling is having a moment ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

1 minute to increase your email open rate

Wednesday, November 27, 2024

Every year we bring the highest quality software to RocketHub for an insane BFCM event. This year is no different! BFCM starts now so check the page below for one new lifetime deeaaal drop each day.

Memo: The Distressed Brand

Wednesday, November 27, 2024

The opposite of brand equity isn't no equity; it's brand apathy. View this email in your browser 2PM (No. 1014). The most recent letter was read by 46.1% of subscribers and this was the top

🔍 How Ridge Scaled to 9-Figures W/ Influencers

Wednesday, November 27, 2024

November 26, 2024 | Read Online All Case Studies 🔍 Learn About Sponsorships 2020 influencer marketing was pay-to-post. In 2024 that sh*t no longer works. In 2025 it's going to be about building a

A letter for you

Wednesday, November 27, 2024

Plus, an announcement you won't want to miss... View in browser ClickBank Logo Hi there, Wow. Time sure does fly. Can you believe there's already less than two months left in 2024!? It feels

🎟️The Quest is calling you

Tuesday, November 26, 2024

And why the HubSpot Blog ages in reverse ... View in browser hey-Jul-17-2024-03-58-50-7396-PM Don't write off a scavenger hunt as mere kids' play. A well-designed hunt can move attendees closer

New Pricing & Black Friday Deal

Tuesday, November 26, 2024

Some updates to my lead program for design agencies ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

The BFCM Playbook To Millions In Sales

Tuesday, November 26, 2024

Come learn how to crush black friday cyber monday for brands ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

🦅 The once-in-a-lifetime deal is here

Tuesday, November 26, 2024

The new 𝕏 API costs forced our hand ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏